US FDA’s Khozin On Defining Big Data, Safety Signaling, And The Patient Experience in Cancer
Executive Summary
The challenge for users of big data "is to develop the human organizational and technical capacity to turn the 'big”' into the 'smart,' through applied analytics to personalize therapies around the distinctive disease characteristics of each patient." Khozin says.